Your browser doesn't support javascript.
loading
A survey of perceptions, attitudes, knowledge and practices of medical oncologists about cancer pain management in Spain
García-Mata, Jesús; Álamo, Cecilio; Castro, Javier de; Contreras, Jorge; Gálvez, Rafael; Jara, Carlos; Llombart, Antonio; Pérez, Concepción; Sánchez, Pedro; Traseira, Susana; Cruz, Juan-Jesús.
Afiliación
  • García-Mata, Jesús; Santa María Nai Hospital. Medical Oncology Department. Orense. Spain
  • Álamo, Cecilio; University of Alcalá de Henares. Department of Pharmacology. Alcalá de Henares. Spain
  • Castro, Javier de; La Paz Hospital. Medical Oncology Department. Madrid. Spain
  • Contreras, Jorge; Carlos Haya Hospital. Radiotherapeutic Oncology Department. Málaga. Spain
  • Gálvez, Rafael; Virgen de las Nieves Hospital. Pain Clinic and Palliative Care Unit. Granada. Spain
  • Jara, Carlos; Alcorcón Hospital. Medical Oncology Department. Alcorcón. Spain
  • Llombart, Antonio; Arnau de Vilanova Hospital. Medical Oncology Department. Valencia. Spain
  • Pérez, Concepción; La Princesa Hospital. Pain Clinic. Madrid. Spain
  • Sánchez, Pedro; Specialty Hospital. Medical Oncology Department. Jaén. Spain
  • Traseira, Susana; Mundipharma Pharmaceuticals. Medical Department. Madrid. Spain
  • Cruz, Juan-Jesús; Universidad de Salamanca (USAL). Hospital Universitario de Salamanca. Instituto de Investigación Biomédica de Salamanca (IBSAL). Salamanca. Spain
Clin. transl. oncol. (Print) ; 20(8): 1061-1071, ago. 2018. tab, graf
Article en En | IBECS | ID: ibc-173690
Biblioteca responsable: ES1.1
Ubicación: BNCS
ABSTRACT
Purpose: To monitor oncologists’ perspective on cancer pain management. Methods: An anonymized survey was conducted in two waves. First, over a convenience sample of oncologists known to be particularly concerned with the management of pain. Second, using a random sample of oncologists. Results: In total, 73 and 82 oncologists participated in the first and second wave, respectively. Many oncologists reported to have good knowledge of analgesic drugs (95.9%), the mechanism of action of opioids (79.5%), and good skills to manage opioid-related bowel dysfunction (76.7%). Appropriate adjustment of background medication to manage breakthrough pain was reported by 95.5% of oncologists. Additionally, 87.7% (68.3% in the second wave, p = 0.035) of oncologists reported suitable opioid titration practices, and 90.4% reported to use co-adjuvant medications for neuropathic pain confidently. On the other hand, just 9.6% of oncologists participated in multidisciplinary pain management teams, and merely 30.3 and 27.1% reported to routinely collaborate with the Pain Clinics or involve other staff, respectively. Only 26.4% of the oncologists of the second wave gave priority to pain pathophysiology to decide therapies, and up to 75.6% reported difficulties in treating neuropathic pain. Significantly less oncologists of the second wave (82.9 vs. 94.5%, p = 0.001) used opioid rotation routinely. Conclusions: Unlike in previous surveys, medical oncologists reported in general good knowledge and few perceived limitations and barriers for pain management. However, multi-disciplinary management and collaboration with other specialists are still uncommon. Oncologists’ commitment to optimize pain management seems important to improve and maintain good practices
RESUMEN
No disponible
Asunto(s)
Buscar en Google
Colección: 06-national / ES Base de datos: IBECS Asunto principal: Dolor en Cáncer / Analgesia / Analgésicos Opioides / Neoplasias Tipo de estudio: Qualitative_research Límite: Humans Idioma: En Revista: Clin. transl. oncol. (Print) Año: 2018 Tipo del documento: Article
Buscar en Google
Colección: 06-national / ES Base de datos: IBECS Asunto principal: Dolor en Cáncer / Analgesia / Analgésicos Opioides / Neoplasias Tipo de estudio: Qualitative_research Límite: Humans Idioma: En Revista: Clin. transl. oncol. (Print) Año: 2018 Tipo del documento: Article